About this trial
This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.
Eligibility criteria
Qualifiers
Consecutive adult patients (18 years of age or older)
Complete medical records and follow-up data available
Disqualifiers
Incomplete procedural or follow-up records
Non-flow-diverter or non-flow-disruptor treatments (e.g., coiling-only cases)
Aneurysms treated with investigational devices not listed within Inclusion Criteria
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Montefiore Medical Center
Lead sponsor
Mayo Clinic
Collaborator
Sarasota Memorial Health Care System
Collaborator
Geisinger Health
Collaborator
University at Buffalo
Collaborator
Thomas Jefferson University
Collaborator
University Health Network, Toronto
Collaborator
Munson Medical Center
Collaborator
HCA Houston Healthcare Kingwood
Collaborator
University of Miami
Collaborator
Robert Wood Johnson University Hospital
Collaborator
Lahey Hospital & Medical Center
Collaborator
Unity Health Toronto
Collaborator
Allina Health System
Collaborator